May 1, 2000

1 Min Read
Abbott Labs, Martek Partner


Abbott Labs, Martek Partner

ABBOTT PARK, Ill.--Abbott Laboratories and Martek Biosciences Corp. signed anon-exclusive licensing agreement that will enable Abbott to introduce infantformula products with Martek's long-chain polyunsaturated fatty acid technology.

Abbott will make cash payments to Martek, which will also receive a royaltywhen the products are introduced. Specifically, Abbott licensed Martek'sdocosahexaenoic acid (DHA) and arachidonic acid (AA). Visit either website, www.abbott.com,or www.martekbio.com, for moreinformation.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like